Medical device testing is the process of quality check of devices. This testing is divided into two types such as first is in –house testing, and second is out-source testing. During in house testing all tests are carried out under the banner of the manufacturers and its team. In Outsource testing all tests are conducted by third party organization.
Increase in spending on preclinical testing in pharmaceutical and medical device manufacturing is expected to boost the global medical device testing market growth. For instance, in 2017, according to International Federation of Manufacturers and Association approximately 149.8 billion is spend on preclinical testing every year. Furthermore, increase in product recall and demand for quality product is expected to propel the growth of global medical device testing market.
Know more about this report: request for sample pages
However, diversity in regulations and policies of government is expected to hamper the growth of global medical device testing market growth. Also, lack of skilled professionals will affect the global medical device testing market growth.
Global Medical Device Testing Market is segmented into by types such as In-house Testing, and Out Source Testing, by Services such as Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing, and Package Validation. Further, Global Medical Device Testing Market is segmented into phase such as Preclinical (Antimicrobial Wound Dressings, Medical Coating, and Others), and Clinical.
Also, Global Medical Device Testing Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as Toxikon Inc., SGS S.A, Eurofins Scientific, LLC, Intertek Group, Pace Analytical Services, Sterigenics International Inc., American Preclinical Services LLC, Charles River Laboratories, WuXi AppTec Group, and North American Science Association.